| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Dermata Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 10K | Jan 4, 2024 | Direct | ||
| Histogen Inc. | President and CEO, Director | Stock Option (right to buy) | 0 | Mar 10, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| DRMA | Dermata Therapeutics, Inc. | Jan 4, 2024 | 1 | $0 | 4 | Jan 5, 2024 | Director |
| HSTO | Histogen Inc. | Mar 10, 2023 | 4 | $0 | 4 | Mar 14, 2023 | President and CEO, Director |
| HSTO | Histogen Inc. | Nov 7, 2022 | 1 | -$2.85M | 4 | Nov 9, 2022 | Interim President and CEO, Director |
| HSTO | Histogen Inc. | Feb 24, 2022 | 1 | $0 | 4 | Feb 25, 2022 | Interim President and CEO, Director |
| DRMA | Dermata Therapeutics, Inc. | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Director |
| HSTO | Histogen Inc. | Nov 8, 2021 | 2 | $0 | 4 | Nov 10, 2021 | Interim President and CEO, Director |
| HSTO | Histogen Inc. | Sep 2, 2021 | 1 | $0 | 4 | Sep 3, 2021 | Director |
| DRMA | Dermata Therapeutics, Inc. | Aug 17, 2021 | 1 | $0 | 4 | Aug 17, 2021 | Director |
| DRMA | Dermata Therapeutics, Inc. | Aug 12, 2021 | 0 | $0 | 3 | Aug 12, 2021 | Director |